European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live04-24 23:23

European equities traded in the US as American depositary receipts were rising late Friday morning, gaining 0.66% at 1,798.36 on the S&P Europe Select ADR Index, which is off 2% for the week so far.

From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and software firm SAP (SAP), which rose 6.4% and 5.6% respectively. They were followed by furniture maker Natuzzi (NTZ) and consumer goods company Unilever (UL), which were up 2.6% and 1.7% respectively.

The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and petroleum refiner Equinor (EQNR), which fell 2.4% and 1.4% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and oil and gas company Eni (E), which were down 1.2% and 0.9% respectively.

The gainers from the UK were led by British American Tobacco (BTI) and InterContinental Hotels Group (IHG), which advanced 2.5% and 2.4% respectively. They were followed by insurance company Prudential (PUK) and educational publisher Pearson (PSO), which increased 1.2% and 0.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical firm NuCana (NCNA) and Autolus Therapeutics (AUTL), which fell 5.1% and 2.7% respectively. They were followed by Trinity Biotech (TRIB) and Silence Therapeutics (SLN), which lost 1.6% and 1% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment